| Schedule of Consolidated Net Loss |
The following table is representative of the significant
expense categories regularly provided to the CODM when managing the Company’s single reporting segment. A reconciliation to the
consolidated net loss for the years ended December 31, 2025 and 2024 is included at the bottom of the table below.
| | |
For the Year Ended December 31, | |
| | |
2025 | | |
2024 | |
| Significant segment expenses | |
| | |
| |
| General and administrative(1) | |
$ | 1,511,008 | | |
$ | 129,418 | |
| Research and development | |
| 634,187 | | |
| - | |
| Professional fees - Licenses and Patents | |
| - | | |
| 288,416 | |
| Professional fees - Other | |
| 3,435,858 | | |
| 2,472,829 | |
| Share based compensation expense | |
| 1,565,212 | | |
| 2,649,573 | |
| Interest expense (income) | |
| 2,313,961 | | |
| 356,603 | |
| Settlement expense | |
| 1,178,000 | | |
| - | |
| Other segment items | |
| (115,066 | ) | |
| 251,572 | |
| Total operating and segment expenses | |
$ | 10,523,160 | | |
$ | 6,148,411 | |
| | |
| | | |
| | |
| Reconciliation of net loss | |
| | | |
| | |
| Change in fair value of warrant liabilities | |
| 28,514 | | |
| 1,961 | |
| Consolidated net loss | |
$ | 10,551,674 | | |
$ | 6,150,372 | |
| 1) | Excludes impairment of licenses and patents. |
|